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Editor-in-Chief,
Journal of the American
College of Cardiologyompetition is an integral factor in virtually all forms of the human endeavor.
The competitive process is perhaps best recognized in athletics, business, or
politics, but is nearly always present whenever 2 or more individuals engage in
he same activity. So it is not too surprising that, although scientific publications (and
edical journals in particular) operate in a genteel environment, competitive forces are
lso present in this arena. The possibility that these forces may have an adverse influence
n the behavior of journals has stimulated this Editor’s Page.
As in any form of competition, the way efforts are directed is determined by the way
hat the score is kept. As I described in an earlier Editor’s Page, a number of criteria
xist by which the success of a journal can be graded. The simplest and most often used
riterion is the impact factor based upon the number of citations to articles published in
journal. This standard is badly flawed and of questionable value, a statement I feel
omfortable making since the impact factor of JACC has done well for the past several
ears. The size of the readership of a journal is an important metric of success, as is fi-
ancial profitability. The number of manuscripts submitted, the quality of the reviews,
nd the rapidity of the decisions regarding publication are additional parameters of the
ealth of a journal. While none of these criteria are perfect, in aggregate they represent
he criteria by which the score is kept when journals compete against one another.
Regardless of the standard applied to evaluate journals, all are strongly dependent
pon the quality of the manuscripts which are published. Clearly, the potential to be
ited is much greater for novel, clinically important papers, and these papers are more
ikely to attract readers and, therefore, advertisers and subscribers. These factors will in
urn lead to more and better submissions so that the cycle is repeated. Thus, the major
oal of every medical journal is to attract that relatively small number of manuscripts
hich contain very original findings which are accurate and will have a significant im-
act on clinical practice.
A variety of strategies have been employed by journals to obtain these high-impact
rticles. As previously stated, rapid review and decision was a mandatory starting point.
ditors thereafter began to solicit the submission of manuscripts which were identified
s potentially having high impact at the time of their abstract presentation. Subse-
uently, some editors sought manuscript submission prior to abstract presentation, and a
ew invited manuscripts upon the completion of study design or the beginning of enroll-
ent. The solicitation initially consisted of expressing a strong interest in the work and
romising to provide an initial decision very rapidly. However, in some cases an agree-
ent to publish prior to completion might be offered contingent upon the study being
mplemented as designed. The ante was increased in many cases by agreeing to publica-
ion simultaneous with the abstract presentation, usually with major coverage by the lay
edia. As time went by the “football fan” phenomenon took place; just as fans in a sta-
ium have to stand if those in front of them do, so editors had to offer the same attrac-
ions as the competing journals. And so, the release of new, clinically relevant data, usu-
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July 17, 2007:286–7 Editor’s Pagelly with great media attention, emerged as a high-scoring
ction in the competition between journals, and became a
agnet to attract high-impact papers.
I should confess at this point that JACC has not been
mmune to participating in the game. From the start we
ave offered expedited review of papers that are of imme-
iate clinical or research importance. We have made each
ssue of the Journal available to the media, and high-
ighted select articles for press releases. Recently we have
ffered expedited review (with the potential for simulta-
eous publication/presentation) to the most highly graded
bstracts selected for presentation at the annual meeting.
e have fully been a part of the football fan phenomenon.
I have been stimulated to write about this topic for
everal reasons. I marvel at the changes that have occurred
uring my years in cardiology. As a junior faculty member
would never have dreamed of asking for expedited re-
iew. The only journals that solicited manuscripts seemed
o be those that were not receiving them otherwise. I can-
ot recall many major media events based upon the publi-
ation of a paper. Times have changed.
I am concerned that the competition between journals
as begun to influence our behavior. The inappropriate
mportance given to the impact factor can bias manuscript
cceptance toward those that are “most citable.” The at-
empt to garner readers may similarly influence the rejec-
ion of good papers which may be of interest to only a
ubset of readers. Expedited reviews may be rushed and
ot as thorough as possible. Based upon the relatively low
ercentage of highly graded abstracts which we have ac-
epted for publication as full manuscripts, the process of
ggressive solicitation of papers at an early stage may be
isappointing for the author and embarrassing for the
ditor.
My greatest concern, however, relates to the seeking of
edia exposure and the fanfare that frequently accompa-
ies publication of select articles. The ability to attract
edia attention appears to have become a criterion of a
uccessful journal. It seems to me that this media orienta-
ion has the ability to influence the selection of manu-
cripts and the portrayal of their results. Although it is
mpossible to know, one wonders if such considerations
layed a role in the recent controversy surrounding a pub- 2ished manuscript which reported a possible increase in
dverse cardiac events with rosiglitazone (1). In addition,
o being a meta-analysis, the study had many limitations.
n fact, the authors themselves were very circumspect in
elineating the limitations in the manuscript and were
ery cautious about the conclusions that could be drawn
rom the data. Nevertheless, not only was the manuscript
apidly accepted for publication, but it was quickly made
vailable online and trumpeted widely to the media, creat-
ng problems for both patients and physicians. This was
one despite the fact that the data were inconclusive and
hat many authorities did not feel that any change in pa-
ient management was indicated (2). It would certainly be
egrettable if the desire to attract high-impact articles,
videnced as such by the ability to garner media attention,
ad any influence on the way the manuscript was han-
led. Perhaps the time has come for all medical journals
o evaluate such policies.
Although medical journals are erudite and genteel, they
re subject to the same competitive pressures as all other
egments of society. This is good as it elicits the best pos-
ible performance. However, competition can provide in-
entives which are capable of negatively influencing be-
avior. I believe that attempting to couple major media
overage with the expedited publication of manuscripts, if
ntended to endorse the importance of the paper and the
ournal, may be one example of such negative influence.
or medical journals, it is probably better to be definitive
han first, to be circumspect rather than to extrapolate
xcessively, to first provide data to those best able to in-
erpret them rather than directly to the lay public.
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